We are live on ! Find out more
CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

10 hedge funds and large institutions have $106K invested in COSCIENS Biopharma Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more capital invested

Capital invested by funds: $95.7K → $106K (+$9.93K)

0.02% less ownership

Funds ownership: 0.27% → 0.25% (-0.02%)

17% less funds holding

Funds holding: 12 → 10 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$21.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$11.2K
3
Bank of America
Bank of America
North Carolina
+$154

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$30.8K
2
Group One Trading
Group One Trading
Illinois
-$5.58K
3
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$582
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$385
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$377
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$35.4K -$30.8K -3,995 -50%
Citadel Advisors
2
Citadel Advisors
Florida
$33.9K +$11.2K +1,459 +58%
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$23.8K +$21.3K +2,770 New
EDRH
4
Edmond de Rothschild Holding
Switzerland
$8.76K – – –
JP Morgan Chase
5
JP Morgan Chase
New York
$1.59K -$231 -30 -14%
Royal Bank of Canada
6
Royal Bank of Canada
Ontario, Canada
$1K -$377 -49 -30%
Osaic Holdings
7
Osaic Holdings
Arizona
$428 – – –
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Quebec, Canada
$302 -$385 -50 -66%
TC
9
Truvestments Capital
Florida
$193 – – –
Bank of America
10
Bank of America
North Carolina
$175 +$154 +20 New
IGWM
11
ICA Group Wealth Management
Colorado
$2 – – –
Group One Trading
12
Group One Trading
Illinois
– -$5.58K -750 Closed
National Bank of Canada
13
National Bank of Canada
Quebec, Canada
– -$582 -77 Closed
UBS Group
14
UBS Group
Switzerland
– -$193 -26 Closed
FWM
15
Focused Wealth Management
New York
– -$112 -15 Closed
TRCT
16
Tower Research Capital (TRC)
New York
– -$2 – –

CSCI Hedge Fund Activity: Q1 2024 in Review

10 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q1 2024, worth a combined $106K — up 10% from $95.7K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CSCI and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $21.3K. The largest seller was Morgan Stanley, cutting an estimated $30.8K.

  • 10 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q1 2024, down from 12 in Q4 2023.
  • Funds reported $106K of COSCIENS Biopharma Inc. Common Stock stock for Q1 2024, up 10% quarter-over-quarter.
  • 2 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q1 2024 and 4 closed out, a net change of -2 holders.
  • The largest COSCIENS Biopharma Inc. Common Stock buyer in Q1 2024 was Bank of Montreal, an estimated $21.3K added.
  • The largest COSCIENS Biopharma Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $30.8K sold.

Based on aggregated 13F filings for Q1 2024.